Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: Survey of 1,000 French community pharmacists

Pharmacy World and Science

Volumn 25, Issue 5, 2003, Pages 197-202

  Allenet, Benoît ^a   Barry, Hervé ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CNRS   (France)

Author keywords

Behaviour; Community pharmacist; France; Generic drugs; Opinion; Professional identity; Strategy Substitution

Indexed keywords

GENERIC DRUG;

ADULT; ARTICLE; BEHAVIOR; COMMUNITY; DRUG LEGISLATION; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACIST; PRESCRIPTION; QUESTIONNAIRE;

ADULT; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; DRUGS, GENERIC; FEMALE; FRANCE; HUMANS; LEGISLATION, DRUG; LEGISLATION, PHARMACY; MALE; MIDDLE AGED; PHARMACISTS; QUESTIONNAIRES;

EID: 0141885431     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025840920988     Document Type: Article

References (19)

1. Decree No. 99-486 of 11 June 1999.
2. Meunier J, Thuillier A. Generic drugs and right of substitution. Relating to the article of the 1999 Social Security Financing Act. Ann Pharm Fr 1999; 57(4): 340-8.
3. Arrêté du 28 avril 1999 relatif aux marges des médicaments remboursables [Article of 28 April 1999 related to the margin of drugs reimbursed by French Social Security.] Journal Officiel of 29 April 1999: 6386-8.
4. Martin E, Rupprecht F. Les enjeux du médicament générique. [The stakes of generic drugs.] Economie et Statistique 1998; 312-313: 55-66.
5. Garattini L, Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy 2000; 51(3): 149-62.
6. Rubak SL, Andersen ML, Mainz J et al. How do pharmacists evaluate the newly introduced system of substitution prescriptions? Ugeskr Laeger 2000; 162(45): 6074-7.
7. Andersen ML, Laursen K, Shaumann M et al. How do patients evaluate the newly introduced system of substitution prescriptions? Ugeskr Laeger 2000; 162(45): 6066-9.
8. Rubak SL, Andersen ML, Mainz J et al. How do practitioners evaluate the newly introduced system of substitution prescriptions? Ugeskr Laeger 2000; 162(45): 6070-3.
9. Nordling S, Lindberg G, Sandberg C, Annel A, Melander A, Rydberg T. Hur gick försöket med generisk substitution i Skane? Stockholm: Apotekarsocietetens Förlag, 2000.
10. Barry H, Allenet B. Analyse des conditions d'intégration des produits génériques dans les officines. Proposition d'une typologie comportementale des pharmaciens. [Analysis of the conditions of generic drugs integration in pharmacies. Proposition for a pharmacist behaviour typology.] Les Nouvelles Pharmaceutiques 2001; 373: 557-562.
11. Statistiques de l'Ordre National des Pharmaciens au 1 er janvier 2000 [Figures of the French National Board of Pharmacists, 1 January 2000] (http://www.ordre.pharmacien.fr).
12. Norgaard, LS, Colberg L, Niemann MR. The role of the Danish community pharmacist: perceptions and future scenarios. Pharm World Sci 2001; 23(4): 159-164.
13. Rubak SL, Andersen ML, Mainz J et al. How do pharmacists evaluate the newly introduced system of substitution prescriptions? Ugeskr Laeger 2000; 162(45): 6074-7.
14. Allaert FA. Evolution de l'image des médicaments génériques dans la population française de 1996 à 1997. [Evolution of the image of generic drugs among the French population from 1996 to 1997.] J Econ Med 1998; 16(1): 93-96.
15. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for prescription drugs. J Am Pharm Assoc 2000; 40(3): 378-383.
16. Andersen ML, Laursen K, Shaumann M et al. How do patients evaluate the newly introduced system of substitution prescriptions? Ugeskr Laeger 2000; 162(45): 6066-9.
17. Rubak SL, Andersen ML, Mainz J et al. How do practitioners evaluate the newly introduced system of substitution prescriptions? Ugeskr Laeger 2000; 162(45): 6070-3.
18. Pelton LE, Strutton D, Smith MC. A political economy perspective: why pharmacists may be reluctant to dispense generic medications. J Hosp Mark 1994; 9(1): 137.
19. Suth DC. Trends of generic substitution in community pharmacies. Pharm World Sci 1999; 21(6): 260-5.